{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:49:04Z","timestamp":1775645344425,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.drudis.2024.104052","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T15:30:52Z","timestamp":1717255852000},"page":"104052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents"],"prefix":"10.1016","volume":"29","author":[{"given":"M\u00e1rcia","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Maria Teresa","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-1671","authenticated-orcid":false,"given":"Joana","family":"Bicker","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2024.104052_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","article-title":"Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective","volume":"20","author":"Kumar","year":"2022","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.drudis.2024.104052_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2021.113874","article-title":"Inhibition of histone deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer\u2019s disease: a review (2010\u20132020)","volume":"226","author":"Li","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2024.104052_b0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2024.104052_b0020","series-title":"Global action plan on the public health response to dementia (2017\u20132025)","first-page":"44","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.drudis.2024.104052_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.drudis.2024.104052_b0030","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/acel.12642","article-title":"HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease","volume":"16","author":"Zhu","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.drudis.2024.104052_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes13081308","article-title":"Epigenetic peripheral biomarkers for early diagnosis of Alzheimer\u2019s disease","volume":"13","author":"Villa","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.drudis.2024.104052_b0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2024.104052_b0045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/1570159X18666200128125641","article-title":"Alzheimer\u2019s disorder: epigenetic connection and associated risk factors","volume":"18","author":"Sharma","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.drudis.2024.104052_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7551","article-title":"Insights into neuroepigenetics through human histone deacetylase PET imaging","volume":"8","author":"Wey","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.drudis.2024.104052_b0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104052_b0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/npp.2012.86","article-title":"The role of histone acetylation in memory formation and cognitive impairments","volume":"38","author":"Peixoto","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2024.104052_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00476","article-title":"Epigenetic modifications in Alzheimer\u2019s neuropathology and therapeutics","volume":"13","author":"Esposito","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0070","doi-asserted-by":"crossref","first-page":"12280","DOI":"10.3390\/ijms222212280","article-title":"Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer\u2019s disease","volume":"22","author":"Maity","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1534\/genetics.114.173492","article-title":"What do you mean, \u201cepigenetic\u201d?","volume":"199","author":"Deans","year":"2015","journal-title":"Genetics"},{"key":"10.1016\/j.drudis.2024.104052_b0080","doi-asserted-by":"crossref","first-page":"16364","DOI":"10.1096\/fj.202001271R","article-title":"Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer\u2019s disease","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2024.104052_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2144\/fsoa-2020-0161","article-title":"The histone modification H3K4me3 is altered at the ANK1 locus in Alzheimer\u2019s disease brain","volume":"7","author":"Smith","year":"2021","journal-title":"Future Sci OA"},{"key":"10.1016\/j.drudis.2024.104052_b0090","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","article-title":"An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease","volume":"52","author":"Nativio","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2024.104052_b0095","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/brain\/awy354","article-title":"Inhibition of EHMT1\/2 rescues synaptic and cognitive functions for Alzheimer\u2019s disease","volume":"142","author":"Zheng","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2024.104052_b0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12014-015-9098-1","article-title":"Histone post-translational modifications in frontal cortex from human donors with Alzheimer\u2019s disease","volume":"12","author":"Anderson","year":"2015","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.drudis.2024.104052_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.14373","article-title":"DNA methylation in the pathology of Alzheimer\u2019s disease: from gene to cognition","volume":"1475","author":"Poon","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.911635","article-title":"Epigenetics in Alzheimer\u2019s disease","volume":"14","author":"Gao","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0115","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/npp.2014.164","article-title":"Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease","volume":"39","author":"Jiang","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2024.104052_b0120","article-title":"The role of non-coding RNAs in Alzheimer\u2019s disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers","volume":"13","author":"Zhang","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0125","first-page":"1","article-title":"Epigenetics of Alzheimer\u2019s disease","volume":"11","author":"Perkovic","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2024.104052_b0130","doi-asserted-by":"crossref","first-page":"11675","DOI":"10.1080\/21655979.2021.2003667","article-title":"Non-coding RNAs and their bioengineering applications for neurological diseases","volume":"12","author":"Das","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.drudis.2024.104052_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1463","article-title":"Noncoding RNAs in Alzheimer\u2019s disease","volume":"9","author":"Idda","year":"2018","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.drudis.2024.104052_b0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12031-019-01364-2","article-title":"Long non-coding RNA BACE1-AS may serve as an Alzheimer\u2019s disease blood-based biomarker","volume":"69","author":"Fotuhi","year":"2019","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/1567205016666190725130134","article-title":"Long non-coding RNA MALAT1 inhibits neuron apoptosis and neuroinflammation while stimulates neurite outgrowth and its correlation with MiR-125b mediates PTGS2, CDK5 and FOXQ1 in Alzheimer\u2019s disease","volume":"16","author":"Ma","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.drudis.2024.104052_b0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/dna.2017.4012","article-title":"Long noncoding RNA EBF3-AS promotes neuron apoptosis in Alzheimer\u2019s disease","volume":"37","author":"Gu","year":"2018","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.drudis.2024.104052_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6690523","article-title":"The histone modifications of neuronal plasticity","volume":"2021","author":"Geng","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/j.drudis.2024.104052_b0160","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fnins.2018.00649","article-title":"The contribution and therapeutic potential of epigenetic modifications in Alzheimer\u2019s disease","volume":"12","author":"Wood","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/genes14020347","article-title":"Histone modifications in Alzheimer\u2019s disease","volume":"14","author":"Santana","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.drudis.2024.104052_b0170","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.drudis.2024.104052_b0175","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.drudis.2024.104052_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDACs: a promising therapy for Alzheimer\u2019s disease","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.drudis.2024.104052_b0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","article-title":"The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease","volume":"6","author":"Yang","year":"2017","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.drudis.2024.104052_b0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2183\/pjab.93.019","article-title":"Chemical and structural biology of protein lysine deacetylases","volume":"93","author":"Yoshida","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0195","series-title":"Alzheimer\u2019s disease: drug discovery","first-page":"151","article-title":"The therapeutic potential of epigenetic modifications in Alzheimer\u2019s disease","author":"Bufill","year":"2020"},{"key":"10.1016\/j.drudis.2024.104052_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2023.115613","article-title":"Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases","volume":"258","author":"Han","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2024.104052_b0205","first-page":"1","article-title":"HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104052_b0210","doi-asserted-by":"crossref","first-page":"E11148","DOI":"10.1073\/pnas.1805436115","article-title":"Inhibition of HDAC3 reverses Alzheimer\u2019s disease-related pathologies in vitro and in the 3xTg-AD mouse model","volume":"115","author":"Janczura","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2024.104052_b0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-171032","article-title":"Frontal cortex epigenetic dysregulation during the progression of Alzheimer\u2019s disease","volume":"62","author":"Mahady","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.drudis.2024.104052_b0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Gr\u00e4ff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104052_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2015.00226","article-title":"Histone acetylation modifiers in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Lu","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0230","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1074\/jbc.M117.794602","article-title":"An acetylation-phosphorylation switch that regulates tau aggregation propensity and function","volume":"292","author":"Carlomagno","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.104052_b0235","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-011112-140216","article-title":"The potential of HDAC inhibitors as cognitive enhancers","volume":"53","author":"Gr\u00e4ff","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.drudis.2024.104052_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0126592","article-title":"Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104052_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16361-y","article-title":"HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease","volume":"11","author":"Pao","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2024.104052_b0250","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuint.2014.07.005","article-title":"Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers","volume":"76","author":"Ishizuka","year":"2014","journal-title":"Neurochem Int"},{"key":"10.1016\/j.drudis.2024.104052_b0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neubiorev.2017.10.004","article-title":"The roles of class I histone deacetylases (HDACs) in memory, learning, and executive cognitive functions: a review","volume":"83","author":"Schmauss","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.drudis.2024.104052_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0265","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1523\/JNEUROSCI.2444-14.2015","article-title":"HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death","volume":"35","author":"Peng","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0270","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","article-title":"HDAC3 is a critical negative regulator of long-term memory formation","volume":"31","author":"McQuown","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0275","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1460-9568.2005.04290.x","article-title":"Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism","volume":"22","author":"Elliott","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2016.00114","article-title":"Aberrant expression of histone deacetylases 4 in cognitive disorders: molecular mechanisms and a potential target","volume":"9","author":"Wu","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0285","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.3390\/ijms22168633","article-title":"Evaluation of class IIa histone deacetylases expression and in vivo epigenetic imaging in a transgenic mouse model of Alzheimer\u2019s disease","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0290","doi-asserted-by":"crossref","first-page":"e12861","DOI":"10.1111\/nan.12861","article-title":"Cytoplasmic HDAC4 recovers synaptic function in the 3\u00d7Tg mouse model of Alzheimer\u2019s disease","volume":"49","author":"Colussi","year":"2023","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.drudis.2024.104052_b0295","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1242\/jcs.046813","article-title":"Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6","volume":"122","author":"Zilberman","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0300","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.0803749105","article-title":"HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation","volume":"105","author":"Parmigiani","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2024.104052_b0305","doi-asserted-by":"crossref","DOI":"10.1126\/science.aas8995","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"369","author":"Magupalli","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.drudis.2024.104052_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115693","article-title":"Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1\u03b2 release","volume":"215","author":"Bockstiegel","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2024.104052_b0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","article-title":"Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease","volume":"68","author":"Julien","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.drudis.2024.104052_b0320","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.tips.2012.05.007","article-title":"The neurobiology of sirtuins and their role in neurodegeneration","volume":"33","author":"Donmez","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106153","article-title":"miR-30a-5p induces A\u03b2 production via inhibiting the nonamyloidogenic pathway in Alzheimer\u2019s disease","volume":"178","author":"Sun","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2024.104052_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.585821","article-title":"SIRT1 and SIRT2 activity control in neurodegenerative diseases","volume":"11","author":"Manjula","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2024.104052_b0335","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1523\/JNEUROSCI.2369-17.2018","article-title":"SIRT1 deacetylates tau and reduces pathogenic tau spread in a mouse model of tauopathy","volume":"38","author":"Min","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0340","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09271","article-title":"A novel pathway regulates memory and plasticity via SIRT1 and miR-134","volume":"466","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2024.104052_b0345","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6782872","article-title":"The beneficial roles of SIRT1 in neuroinflammation-related diseases","volume":"2020","author":"Jiao","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.drudis.2024.104052_b0350","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12679","article-title":"SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"17","author":"Lee","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.drudis.2024.104052_b0355","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1038\/srep25628","article-title":"p53-dependent SIRT6 expression protects A\u03b242-induced DNA damage","volume":"6","author":"Jung","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104052_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111062","article-title":"Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP\/PS1 transgenic mice","volume":"40","author":"Bai","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2024.104052_b0365","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.3390\/ijms23169027","article-title":"SIRT7 deficiency protects against A\u03b242-induced apoptosis through the regulation of NOX4-derived reactive oxygen species production in SH-SY5Y cells","volume":"23","author":"Mizutani","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0370","article-title":"Regulatory decisions diverge over aducanumab for Alzheimer\u2019s disease","volume":"376","author":"Lythgoe","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2024.104052_b0375","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2024.104052_b0380","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2024.104052_b0385","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin A\/ACY-1215 improves cognition in Alzheimer\u2019s disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.drudis.2024.104052_b0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202304545","article-title":"Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer\u2019s disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.drudis.2024.104052_b0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","article-title":"Valproic acid as a promising agent to combat Alzheimer\u2019s disease","volume":"81","author":"Zhang","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.drudis.2024.104052_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2019.00062","article-title":"Valproic acid stimulates hippocampal neurogenesis via activating the Wnt\/\u03b2-catenin signaling pathway in the APP\/PS1\/Nestin-GFP triple transgenic mouse model of Alzheimer\u2019s disease","volume":"11","author":"Zeng","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-024-01384-0","article-title":"Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP\/PS1 Alzheimer\u2019s disease mouse model by regulating the expression of APP secretases","volume":"16","author":"Zhang","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.drudis.2024.104052_b0410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-190120","article-title":"Sodium butyrate reduces brain Amyloid-\u03b2 levels and improves cognitive memory performance in an Alzheimer\u2019s disease transgenic mouse model at an early disease stage","volume":"74","author":"Fernando","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.drudis.2024.104052_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00746-8","article-title":"Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and A\u03b2 clearance in APP\/PS1 mice","volume":"13","author":"Su","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.drudis.2024.104052_b0420","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/1673-5374.265564","article-title":"Action of trichostatin A on Alzheimer\u2019s disease-like pathological changes in SH-SY5Y neuroblastoma cells","volume":"15","author":"Li","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2024.104052_b0425","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/NEN.0b013e318283114a","article-title":"Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model","volume":"72","author":"Zhang","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.drudis.2024.104052_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acel.13895","article-title":"Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer\u2019s disease","volume":"22","author":"Marinho","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.drudis.2024.104052_b0435","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/cns.14102","article-title":"Apicidin attenuates memory deficits by reducing the A\u03b2 load in APP\/PS1 mice","volume":"29","author":"Luo","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.drudis.2024.104052_b0440","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau","volume":"28","author":"Green","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2024.104052_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-015-0142-9","article-title":"Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"7","author":"Cuadrado-Tejedor","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.drudis.2024.104052_b0450","article-title":"The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity","volume":"9","author":"Meng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104052_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-94923-w","article-title":"A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer\u2019s disease and tauopathy in mice","volume":"11","author":"Onishi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104052_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114090","article-title":"Histone deacetylase 6 inhibitors with blood-brain barrier penetration as a potential strategy for CNS-Disorders therapy","volume":"229","author":"Gu","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2024.104052_b0465","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cmdc.201900174","article-title":"Histone deacetylase inhibitors as multitarget ligands: new players in Alzheimer\u2019s disease drug discovery?","volume":"14","author":"De Simone","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2024.104052_b0470","doi-asserted-by":"crossref","first-page":"35444","DOI":"10.1074\/jbc.M112.394544","article-title":"Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death","volume":"287","author":"Bardai","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2024.104052_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112193","article-title":"Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer\u2019s disease","volume":"192","author":"Tseng","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2024.104052_b0480","article-title":"HDAC6 regulates mitochondrial transport in hippocampal neurons","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2024.104052_b0485","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1073\/pnas.1501441112","article-title":"HDAC inhibition prevents white matter injury by modulating microglia\/macrophage polarization through the GSK3\u03b2\/PTEN\/Akt axis","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2024.104052_b0490","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-019-49784-9","article-title":"Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-\u03b2 probes","volume":"9","author":"Choi","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2024.104052_b0495","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/npp.2016.163","article-title":"A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer\u2019s disease mice","volume":"42","author":"Cuadrado-Tejedor","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drudis.2024.104052_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.700947","article-title":"Characterization of histone deacetylase mechanisms in cancer development","volume":"11","author":"Hai","year":"2021","journal-title":"Front Oncol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644624001776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T19:35:55Z","timestamp":1720121755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644624001776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1359644624001776"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104052","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2024.104052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104052"}}